Evidence map›Paper›PMID 40449343›Full record

ArticleJournal of neuroimmunology2025

Heightened effector immune cell infiltration of the hippocampus concurrently with brain ventricular volume expansion in aged APP/PS1 mice.

Mark A Maynes, Carley A Owens, Delaney M Anani-Wolf, Zachariah P Tritz, Fang Jin, Michael J Hansen, Marina Seady, Aaron J Johnson

Abstract read
In one paragraph

Article in Journal of neuroimmunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mark A MaynesGraduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.
Carley A OwensDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Delaney M Anani-WolfDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Zachariah P TritzDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Fang JinDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Michael J HansenDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Marina SeadyDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Aaron J JohnsonDepartment of Immunology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: Johnson.aaron2@mayo.edu.

Funding

CD8 T cell mediated disruption of Blood Brain Barrier Tight JunctionsR01NS103212 · NINDS · MAYO CLINIC ROCHESTER · PI Aaron J Johnson · 2017 to 2026
$4.6M
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - SupplementRF1NS122174 · NINDS · MAYO CLINIC ROCHESTER · PI JOHNSON, AARON J · 2021 to 2023
$2.0M
Training Program in ImmunologyT32AI170478 · NIAID · MAYO CLINIC ROCHESTER · PI Virginia Smith Shapiro · 2022 to 2026
$1.4M
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and TauopathyR01NS122174 · NINDS · MAYO CLINIC ROCHESTER · PI JOHNSON, AARON J · 2024 to 2025
$1.2M
NIAID NIH HHS T32 AI170478NINDS NIH HHS R01 NS103212NINDS NIH HHS R01 NS122174NINDS NIH HHS RF1 NS122174
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of dementia for which the role of neuroinflammation is becoming more realized. Recent studies have shown that immune cells infiltrate the hippocampus and the cortex of AD patients as well as mouse models of the disease. In this study, we employed T2-weighted magnetic resonance imaging (MRI) to view changes in ventricular volume in addition to spectral flow cytometric assessment of the hippocampus infiltrating immune profile in the aged APP/PS1 mice. Aged APP/PS1 mice present with increased size of lateral, dorsal, and ventral ventricles plus increased numbers of hippocampus infiltrating effector immune cell subsets, including CD8 T cells expressing IFNγ, granzyme B, and perforin along with other cell types such as γδ T cells, neutrophils, and NK cells. The concurrent increase in effector cell types with ventricular enlargement expands the putative mechanism of brain atrophy in the APP/PS1 mouse model to include cytolytic functions of these aforementioned immune cell subsets.

Indexed as

AgingAlzheimer DiseaseCerebral VentriclesHippocampusAmyloid beta-Protein PrecursorAnimalsDisease Models, AnimalMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMice, TransgenicPresenilin-1Amyloid beta-Protein PrecursorPresenilin-1Alzheimer's diseaseBrain atrophyImmune infiltration

Identifiers

PMID40449343
PMCPMC12286741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.